Reported about 11 hours ago
Kimberly-Clark announced its acquisition of Tylenol's parent company Kenvue for nearly $50 billion, forming a major consumer products conglomerate with anticipated annual revenues of $32 billion. The deal comes after Kenvue faced stock declines amid controversial claims linking its products to autism. With 10 billion-dollar brands such as Huggies and Listerine, the merger is set to close in the latter half of next year, although Kenvue is currently under legal scrutiny regarding its marketing practices.
Source: YAHOO